Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy

A molecular tumor board (MTB) is often used as a platform that integrates clinical and molecular parameters for clinical decision making. Here, the authors review the outcome of 715 cancer patients presented at their institution’s MTB, and demonstrate that patients who received a MTB-recommended reg...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shumei Kato, Ki Hwan Kim, Hyo Jeong Lim, Amelie Boichard, Mina Nikanjam, Elizabeth Weihe, Dennis J. Kuo, Ramez N. Eskander, Aaron Goodman, Natalie Galanina, Paul T. Fanta, Richard B. Schwab, Rebecca Shatsky, Steven C. Plaxe, Andrew Sharabi, Edward Stites, Jacob J. Adashek, Ryosuke Okamura, Suzanna Lee, Scott M. Lippman, Jason K. Sicklick, Razelle Kurzrock
Format:	article
Language:	EN
Published:	Nature Portfolio 2020
Subjects:	Science Q
Online Access:	https://doaj.org/article/be2daa0bb1884adbb304041e571d8edf
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy

Similar Items